Edition:
India

Medigene AG (MDG1k.DE)

MDG1k.DE on Xetra

8.86EUR
23 Apr 2019
Change (% chg)

-- (--)
Prev Close
€8.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
111,320
52-wk High
€16.71
52-wk Low
€7.20

About

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modi... (more)

Overall

Beta: 1.60
Market Cap(Mil.): €218.93
Shares Outstanding(Mil.): 24.56
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates